“CC#139511: A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma

Sponsor
University of California and San Francisco

Protocol Number
UCSF 139511

To Learn More Call
201-510-0910